2017 American Transplant Congress
Porta Systemic Shunts Helps Us to Delay or Avoid Liver Transplantation in Patients with Portal Hypertension Post Kasai Operation for Biliary Atresia.
Paediatric Surgery and Transplant Surgery, Children's Hospital at Westmead, Sydney, NSW, Australia
We present a series of 10 patients who had Kasai operation for biliary atresia in the neonatal period. These patients had optimally functioning liver in…2017 American Transplant Congress
Disparities in Access to the Liver Transplant Wait List: A Statewide Analysis.
Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA
Background:Racial disparities in access to the liver transplant wait list for patients with end-stage liver disease (ESLD) are thought to be attributable to differences in…2017 American Transplant Congress
Are ICD-9 V Codes Representative of the Liver Transplant Wait List?
Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA
Background: Disparities in liver transplantation once wait listed are well-described, but little is known about how and why only 20% of end-stage liver disease patients…2016 American Transplant Congress
Liver Transplantation in Patients Actively Drinking Less Than 6 Months Before Transplant Presenting with Acute Decompensation: A Single-Center Experience.
Background: Alcohol is amongst the leading causes of liver disease worldwide. Most centers have a 6-month abstinence requirement before transplantation candidacy. Mortality rates for acute…2016 American Transplant Congress
Physical Disability on the Liver Transplant Waitlist: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.
University of California, San Francisco, San Francisco, CA.
Background: Cirrhosis leads to sarcopenia and functional decline that can severely impact one's ability to function at home and in society. Self-reported disability scales to…2016 American Transplant Congress
Hematopoietic Progenitor Cells and Monocyte Subsets and Hepatic Decompensation in Patients Referred for Liver Transplant Evaluation.
Background: Abnormal hepatic and systemic angiogenesis is an important component of advanced liver disease. Circulating hematopoietic progenitor cells (HPCs) and M2 monocytes are thought to…2016 American Transplant Congress
Acute-on-Chronic Liver Failure Admissions Cost 3 Times More Than Non-ACLF Related Admissions.
Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX.
Background: Acute-on-chronic liver failure (ACLF) is associated with significant resource utilization. However, the relative charges associated with ACLF are not established.Methods: We examined cirrhotics admitted…2016 American Transplant Congress
Transcatheter Aortic Valve Replacement (TAVR) for Severe Aortic Stenosis as a Bridge to Liver Transplantation.
Ochsner Medical Center, New Orleans, LA.
Background: Historically, severe symptomatic aortic stenosis (AS) has been corrected surgically with aortic valve replacement. In patients with end stage liver disease (ESLD), cardiac surgery…2016 American Transplant Congress
The Therapeutic Potential of Human Liver-Derived Stem Cell Transplantation in a Cirrhotic Liver Rat Model.
Cirrhosis is a long-term consequence of chronic hepatic injury and there are no effective treatment methods. Previous studies suggested that MSCs may ameliorate fibrogenesis through…2016 American Transplant Congress
Is SVR Associated with Improved Hepatic Function in Hepatitis C Gen 1 Pts with Cirrhosis 1 Year After Completing Treatment with Sofosbuvir + Simeprevir +/- Ribavirin?
Background: Combination antiviral therapy involving Sofosbuvir (SOF) & Simeprevir (SIM) +/- Ribavirin (RBV) is a relatively safe & effective Tx option in pts with gen…
American Transplant Congress abstracts